GILL DAVID N

Average Profitability
4.25%
Insider Buys Quantity
10
Insider Buys Sum
$205,654.20
Insider Sells Quantity
6
Insider Sells Sum
$630,624.80

Insider Activity of GILL DAVID N

According to the SEC Form 4 filings, GILL DAVID N, being in a position of

  1. director at Evolus, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10361 share for $131,010,
    over all time since 2018-12-14, has bought 10000 shares for $131,200, and sold 15361 share for $199,090.

The largest purchase of all time was on 2018-12-14 and amounted to 6000 shares of Evolus, Inc. for $76,600.

The largest sale of all time was on 2020-11-03 and amounted to 8000 shares of Y-mAbs Therapeutics, Inc. for $224,640.

Biography of GILL DAVID N

No biography is available at this moment.

2024-05-14SaleEvolus, Inc.
EOLS
director
6,718
0.0106%
$12.60$84,654+14.93%
2024-05-13SaleEvolus, Inc.
EOLS
director
3,643
0.0059%
$12.72$46,356+13.96%
2022-05-13SaleEvolus, Inc.
EOLS
5,000
0.0092%
$13.62$68,080-32.59%
2021-01-19SaleY-mAbs Therapeutics, Inc.
YMAB
director
2,000
0.0048%
$46.52$93,045-34.59%
2020-11-18SaleY-mAbs Therapeutics, Inc.
YMAB
director
4,000
0.0063%
$28.46$113,850-25.4%
2020-11-03SaleY-mAbs Therapeutics, Inc.
YMAB
director
8,000
0.0123%
$28.08$224,640-25.41%
2019-06-13PurchaseEvolus, Inc.
EOLS
director
4,000
0.0143%
$13.65$54,600-11.33%
2018-12-14PurchaseEvolus, Inc.
EOLS
director
6,000
0.0221%
$12.77$76,600+27.73%
2017-08-16PurchaseOcugen, Inc.
OCGN
director
6,000
0.027%
$1.81$10,878+33.74%
2017-05-16PurchaseOcugen, Inc.
OCGN
director
6,000
0.027%
$1.68$10,080+22.02%
2016-12-15PurchaseOcugen, Inc.
OCGN
director
6,000
0.0359%
$1.65$9,900+10.56%
2016-12-09PurchaseOcugen, Inc.
OCGN
director
10,000
0.0602%
$1.92$19,200-4.84%
2007-05-16PurchaseLeMaitre Vascular, Inc.
LMAT
director
800
0.0052%
$6.05$4,840+1.64%
2007-05-15PurchaseLeMaitre Vascular, Inc.
LMAT
director
200
0.0013%
$6.03$1,206+2.65%
2007-05-09PurchaseLeMaitre Vascular, Inc.
LMAT
director
1,000
0.0065%
$6.25$6,250-0.64%
2006-10-31PurchaseLeMaitre Vascular, Inc.
LMAT
director
2,000
0.0202%
$6.05$12,100+3.14%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.